about
Ethical Issues in the Management of Renal Cell Carcinoma.Oncologic outcomes in men with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institution international study.Improving our understanding of papillary renal cell carcinoma with integrative genomic analysis.Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell CarcinomaSecondary infections of thoracic and abdominal aortic endografts.Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy.Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.Industry Payments to Urologists in 2014: an Analysis of the Open Payments Program.Intracrine androgen biosynthesis in renal cell carcinoma.Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy.Long-Term Outcomes of Using Hyaluronic Acid-Carboxymethylcellulose Adhesion Barrier Film on the Neurovascular Bundle.Ureteral Stent-Associated Pain: A Review.Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.Renal cell carcinoma: the search for a reliable biomarker.Medications and surgical interventions for benign prostatic hyperplasia are potential confounders of prostate-specific antigen.Pediatric hospitalizations for upper urinary tract calculi: Epidemiological and treatment trends in the United States, 2001-2014.Safety of Robot-Assisted Radical Prostatectomy with Pneumoperitoneum of 20 mm Hg: A Study of 751 Patients.Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study.The Receipt of Industry Payments is Associated with Prescribing Promoted Alpha-Blockers and Overactive Bladder Medications.Off-Target Effect of Sildenafil on Postsurgical Erectile Dysfunction: Alternate Pathways and Localized Delivery System.Real-world Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and SpendingReconstruction of late-onset transplant ureteral stricture diseaseVariation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizationsNational Trends in Active Surveillance for Prostate Cancer: Validation of Medicare Claims-based AlgorithmsImpact of Medicare Office Visit Payment Reform on Urologic PracticesAccuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinomaTrends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer DatabaseMedicare Accountable Care Organizations and Use of Potentially Low-Value ProceduresEditorial Comment
P50
Q30724257-737531FA-486F-457C-BAB6-668F57C3D27EQ35732299-ED36D455-BCD3-4680-AC2E-82B6ACEA4248Q36829230-0ADE9267-1385-4BF5-86D9-71A7DA34D76DQ37179808-2140032B-9D83-474F-B4D1-926A8EF31CC6Q37355319-A777E906-B676-425B-AEF9-9696F842EBC3Q37524117-7CBC4D0E-F174-45AD-B282-42129AB01BD1Q37527224-3F0D135C-B938-411C-B22B-A0DF9B81C6A5Q38641883-83FE47D8-61A3-4B62-A39C-E9EC89068876Q38714201-EC780DF8-3D53-4AD5-B251-98911D478C4BQ38755877-51C7F85F-483B-4F62-B528-15293321EEE4Q38806689-C765BC5D-13FD-4D9F-975F-0CC45196D5EAQ38820119-4DDE6295-D7D8-4BF1-8F67-D254ADD14C75Q38896821-11499394-2D22-4115-A31B-E9D39C32E615Q40572565-AC713254-03DE-4D38-973A-EF7CE81A2E28Q41197945-517A875F-81E6-41E0-AEB9-5F83955D5BDBQ44904451-3295096D-D6F5-48FD-817C-7411FF8FFEEFQ47623789-7979C547-1887-4646-937A-B5FDDCB26B05Q47718040-E6220809-B180-4E1D-B554-CFEA056AF571Q50866461-A164D694-7957-41C8-952D-1069E007151FQ52572355-E705A923-97B9-4557-B909-55CF3021A1DBQ52837026-C1C359F9-29AB-4B69-BA06-2A1D010E9A96Q58577856-8106CFFA-F6B3-4156-AFF6-3CF7662AF274Q84999389-76DC9110-464E-445F-BD81-DEA0AA67EB4DQ89114011-20C0FD71-7B24-4CD8-8C5B-3FB140E7D840Q89499507-A5FAAFAD-FB88-4AC4-AA9F-F9A8EACFAEF0Q91223846-D0443756-15BE-4ACF-811F-A18770B9F373Q91685473-42E62518-0A31-464C-93A5-1B4614666FD2Q93182721-854E78EC-5828-44B8-9676-AE7A36E84E4AQ93372818-2542C33E-63A9-4528-ABA7-841DEF363287Q95550242-BE7D237A-618D-470E-9F3B-7D536AEDDB54
P50
description
researcher ORCID ID = 0000-0001-5754-4445
@en
name
Parth K Modi
@ast
Parth K Modi
@en
Parth K Modi
@es
Parth K Modi
@nl
type
label
Parth K Modi
@ast
Parth K Modi
@en
Parth K Modi
@es
Parth K Modi
@nl
prefLabel
Parth K Modi
@ast
Parth K Modi
@en
Parth K Modi
@es
Parth K Modi
@nl
P1153
24528889900
P31
P496
0000-0001-5754-4445